Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients

Abstract Continuous subcutaneous (SubQ) treprostinil is an effective therapy for pediatric patients diagnosed with pulmonary hypertension (PH). To date, the clinical characteristics and factors associated with failure to tolerate this therapy have not been described. The purpose was to describe pati...

Descripció completa

Dades bibliogràfiques

Autors principals:	Julia McSweeney, Elizabeth Colglazier, Jasmine Becerra, Brienne Leary, Kathleen Miller‐Reed, Stephen Walker, Katy Tillman, Melissa Magness, Michelle Ogawa, Whitney Bannon, Tisha Kivett, Emma O. Jackson, Anne Davis, Cathy Shepard, Susan Richards, Elise Whalen, Shannon Engstrand, Zachary DiPasquale, Jean A. Connor
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2023-04-01
Col·lecció:	Pulmonary Circulation
Matèries:	advanced practice nursing prostacyclin pulmonary hypertension treprostinil
Accés en línia:	https://doi.org/10.1002/pul2.12224
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!